These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36902232)

  • 1. Halloysite Nanotubes and Sepiolite for Health Applications.
    Biddeci G; Spinelli G; Colomba P; Di Blasi F
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halloysite nanotubes in analytical sciences and in drug delivery: A review.
    Fizir M; Dramou P; Dahiru NS; Ruya W; Huang T; He H
    Mikrochim Acta; 2018 Jul; 185(8):389. PubMed ID: 30046919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clay nanoparticles as pharmaceutical carriers in drug delivery systems.
    Dong J; Cheng Z; Tan S; Zhu Q
    Expert Opin Drug Deliv; 2021 Jun; 18(6):695-714. PubMed ID: 33301349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoclay-based drug delivery systems and their therapeutic potentials.
    Khatoon N; Chu MQ; Zhou CH
    J Mater Chem B; 2020 Aug; 8(33):7335-7351. PubMed ID: 32687134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold.
    Santos AC; Ferreira C; Veiga F; Ribeiro AJ; Panchal A; Lvov Y; Agarwal A
    Adv Colloid Interface Sci; 2018 Jul; 257():58-70. PubMed ID: 29887382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterials: A Review about Halloysite Nanotubes, Properties, and Application in the Biological Field.
    Biddeci G; Spinelli G; Colomba P; Di Blasi F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clay-based drug-delivery systems: what does the future hold?
    Giuseppe ; Riela S; Fakhrullin RF
    Ther Deliv; 2017 Jul; 8(8):633-646. PubMed ID: 28730937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharides/Halloysite nanotubes for smart bionanocomposite materials.
    Bertolino V; Cavallaro G; Milioto S; Lazzara G
    Carbohydr Polym; 2020 Oct; 245():116502. PubMed ID: 32718613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural halloysite nanotubes /chitosan based bio-nanocomposite for delivering norfloxacin, an anti-microbial agent in sustained release manner.
    Barman M; Mahmood S; Augustine R; Hasan A; Thomas S; Ghosal K
    Int J Biol Macromol; 2020 Nov; 162():1849-1861. PubMed ID: 32781129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubule Nanoclay-Organic Heterostructures for Biomedical Applications.
    Liu M; Fakhrullin R; Novikov A; Panchal A; Lvov Y
    Macromol Biosci; 2019 Apr; 19(4):e1800419. PubMed ID: 30565394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous inorganic nanoscale particles for drug adsorption and controlled release.
    Cavallaro G; Lazzara G; Fakhrullin R
    Ther Deliv; 2018 Mar; 9(4):287-301. PubMed ID: 29495930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances of Halloysite Nanotubes in Biomedical Applications.
    Jiang Z; Sun S; Liu J; Sun X
    Small; 2024 Jan; 20(2):e2306169. PubMed ID: 37670217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating Halloysite Nanotubes as a Potential Platform for Oral Modified Delivery of Different BCS Class Drugs: Characterization, Optimization, and Evaluation of Drug Release Kinetics.
    Husain T; Shoaib MH; Ahmed FR; Yousuf RI; Farooqi S; Siddiqui F; Imtiaz MS; Maboos M; Jabeen S
    Int J Nanomedicine; 2021; 16():1725-1741. PubMed ID: 33688188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past, Present and Future Perspectives on Halloysite Clay Minerals.
    Massaro M; Noto R; Riela S
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties and Applications of Polyvinyl Alcohol, Halloysite Nanotubes and Their Nanocomposites.
    Gaaz TS; Sulong AB; Akhtar MN; Kadhum AA; Mohamad AB; Al-Amiery AA
    Molecules; 2015 Dec; 20(12):22833-47. PubMed ID: 26703542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deep delve into the chemistry and biocompatibility of halloysite nanotubes: A new perspective on an idiosyncratic nanocarrier for delivering drugs and biologics.
    Dube S; Rawtani D; Khatri N; Parikh G
    Adv Colloid Interface Sci; 2022 Nov; 309():102776. PubMed ID: 36183621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomedical potential of clay nanotube formulations and their toxicity assessment.
    Santos AC; Pereira I; Reis S; Veiga F; Saleh M; Lvov Y
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1169-1182. PubMed ID: 31486344
    [No Abstract]   [Full Text] [Related]  

  • 18. Halloysite clay nanotubes for controlled release of protective agents.
    Lvov YM; Shchukin DG; Möhwald H; Price RR
    ACS Nano; 2008 May; 2(5):814-20. PubMed ID: 19206476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halloysite clay nanotubes for controlled release of protective agents.
    Abdullayev E; Lvov Y
    J Nanosci Nanotechnol; 2011 Nov; 11(11):10007-26. PubMed ID: 22413340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micropatterning of biologically derived surfaces with functional clay nanotubes.
    Liu M; Fakhrullin R; Stavitskaya A; Vinokurov V; Lama N; Lvov Y
    Sci Technol Adv Mater; 2024; 25(1):2327276. PubMed ID: 38532983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.